ERBB2 and neoplasm: Since tumor heterogeneity is one of the major obstacles for drug effectiveness and resistance, we explored whether heterogeneous HER2 gene amplification and HER2 protein expression levels contribute to the higher IC50 in 3D cultured spheroids or aggregates.